Medical Device Fraud: Following the Medical Device to the False Claim

Medical device fraud can turn a surgeon’s product choice, a manufacturer’s sales instructions or a concealed defect into a false government claim. The manufacturer sells the implant, the physician chooses it, and the hospital bills for the procedure. When a kickback drives that choice, the patient gets the implant and taxpayers get the bill. The company influencing the claim may never submit a bill to Medicare itself. For an insider, the connection may sit in a surgeon-payment spreadsheet, a product complaint, a reimbursement guide or a credit memo that never reached billing. Those records explain what the claim leaves out.

How Does Reimbursement Work for Medical Devices?

Most implanted medical devices are included in Medicare’s payment for the procedure or hospital stay. The hospital buys the implant, but the physician often makes or strongly influences the choice of brand and type. The Health and Human Services Inspector General calls these physician preference items.

The hospital may have the implant on its shelf before it owns it. Under consignment arrangements, the manufacturer can retain ownership until use or implantation. The operation then triggers the sale. The product’s arrival, its use and the hospital’s purchase can appear in different records on different dates.

A representative may manage that inventory and the instrument trays that support the procedure. The American College of Surgeons describes the representative as an educator and facilitator in the operating room, with clinical decisions remaining with the physician.

For inpatient care, the diagnosis-related group supplies a payment for the stay with the medical device cost inside it. Outpatient procedure payments also generally package implant costs. A medical device can have a reported code and charge on the hospital’s claim while its cost remains inside the procedure payment. That distinction matters when a sales presentation promises the hospital a margin on each operation.

Defined exceptions include inpatient new technology add-on payments and outpatient transitional pass-through payments. Durable medical equipment, prosthetics, orthotics and supplies billed separately under Medicare Part B follow another path. There, the supplier’s order, delivery and billing records can be central.

The physician’s office has another arrangement. Medical device costs can sit within the practice-expense portion of a professional payment. The equipment invoice describes what the practice bought. The professional claim describes the service. A manufacturer selling into that setting can reach payment through the provider’s procedure and coding decisions.

Direct federal purchases have their own transaction as well: the government buys the medical device under a contract, with the invoice and contract terms carrying the payment question.

Why the Surgeon’s Choice Is Worth Paying For

The surgeon may influence the choice of medical device repeatedly, while the hospital purchases the product and the health care program pays for the procedure. That makes the surgeon’s business valuable far beyond a consulting fee.

Medical device companies use surgeons to develop products, evaluate instruments, teach techniques and gather information after a product reaches the market. In kickback cases, the revealing evidence often sits beneath those descriptions: what work was delivered, how compensation was calculated and what happened when implant use fell.

Life Spine agreed to pay $5.5 million in a November 2019 civil settlement and admitted that surgeons receiving consulting fees, royalties or intellectual property payments accounted for approximately half its domestic spinal-product sales between 2012 and 2018.

What Evidence Is Needed to Prove Fraud?

Medical device fraud evidence can sit in sales instructions, complaint files and payment records that show the manufacturer’s decision. The operative record, coverage information and bill can show what that decision caused.

An ordinary hospital claim does not identify the implant by its unique device identifier. It can show a spinal fusion or a defibrillator procedure without identifying the particular model used. The implant log and product records supply that missing identity. Consignment records, purchase records and manufacturer credit memos can then connect the physical product to the hospital’s accounting.

The same reconciliation applies to physician payments. Open Payments records carry the manufacturer’s description of a transfer. Calendars, consulting work, sales reports and operating schedules can show what lay behind that description. A payment recorded as consulting and an internal report measuring implant sales tell different parts of the story.

The 2020 review A Forensic Accountant’s Guide to the Most Potent Federal Laws Used Against Healthcare Fraud, published in the Journal of Forensic and Investigative Accounting, explains why a payment inquiry extends beyond a check: the kickback framework reaches indirect compensation and benefits supplied in kind. In medical device cases, the corresponding records can include free equipment, practice marketing, travel and payments to people or businesses around the physician. Following only the consulting ledger can leave much of the arrangement unseen in a medical device False Claims Act case.

Who Can See the Connection?

Sales representatives, clinical specialists, quality employees and hospital billing staff can each see a different part of a medical device scheme. A representative may know why a surgeon received a contract. A quality employee may know when a failure pattern reached management. A hospital employee may know why a credit disappeared between purchasing and billing.

For medical device sales representatives and operating-room specialists, the useful records include training materials, product-use reports, consultant arrangements and instructions passed to the clinical team. They may also know which company representative was present when a product was used or modified.

Quality and regulatory employees work with product complaints, test results, corrective actions and reporting decisions. Supply-chain staff see returned medical devices and credits. Reimbursement specialists and coders see the coverage rules, admission decisions, coding advice and claim edits. A clinician’s account can connect those records to what the patient needed and what happened during treatment.

Those roles have already produced cases. A cardiac nurse and a health care reimbursement consultant brought the whistleblower case behind the hospitals’ defibrillator coverage settlements. Two former Kyphon employees brought the case over inpatient kyphoplasty. Their knowledge reached different parts of the payment chain.

A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers. The starting point is the part of the business you can explain: the payment, the instruction, the product failure or the bill.

What Are Some Examples of Medical Device Fraud?

Medical device fraud cases include payments influencing implant selection, promotion that causes noncovered procedures, concealed product failures, false coding and replacement credits withheld from the payer. Each pattern changes a different part of the transaction.

Medical Device Kickbacks Behind Implant Selection

Medical device kickback allegations led to Arthrex‘s $16 million settlement in November 2021. The government alleged that royalties purportedly paid for a surgeon’s contributions to orthopedic products were intended to induce the surgeon’s use and recommendation of Arthrex products, causing false Medicare claims.

Innovasis and two senior executives agreed to a $12 million civil settlement in May 2024 over allegations of kickbacks through consulting fees, intellectual property purchases, registry payments, performance shares and hospitality.

The benefit can also reach the practice without appearing as physician compensation. Alleged medical device inducements have included patient marketing, referral events, office support, free equipment and payments to physician-owned venues. A manufacturer can absorb a customer’s business expenses and receive product orders in return. That makes the practice-development budget, event records and recipient ownership relevant alongside the surgeon’s contract. Registry payments raise a similar question about what the payment bought: the study records describe the work performed, while enrollment and implant records show the product use.

Physician-owned distributorships put the surgeon on the selling side as well. The evidence includes ownership, distributions, product orders and terms that tie continued participation to use. The return on the surgeon’s investment can depend on implants selected for the surgeon’s own patients.

Speaker-program allegations have included LivaNova’s payments to high-referring epilepsy physicians for events attended primarily by the physicians and their own staff.

False Open Payments reporting can conceal who benefited from a manufacturer’s spending. The government alleged that Medtronic underreported payments to a restaurant it knew a surgeon owned.

Off-Label Promotion and the Product Sold

Off-label medical device promotion and kickback allegations were resolved in NuVasive‘s $13.5 million settlement in July 2015. The whistleblower’s complaint alleged that training and promotional materials represented CoRoent XL implants as indicated for uses beyond their authorization.

For an insider, the revealing comparison is between the medical device’s labeling, what the sales team taught and the procedure the provider billed.

FDA clearance and approval also describe different pathways. A manufacturer may change a medical device’s design or manufacturing process after authorization. Its change records and submissions to the FDA show what it changed and what it told the agency. Medicare coverage is a separate decision about payment eligibility.

False FDA Clearance Claims

Medical devices can be sold as authorized even though they lack required FDA clearance or approval. CareFusion agreed to a $3.3 million civil settlement in May 2019 and admitted buying and selling medical devices without the required FDA approval or clearance, under an unsupported claim that they qualified for the pre-1976 exception.

Unnecessary Implants and Procedures

Unnecessary implants and procedures generate claims for treatment the patient did not need. Saint Joseph Health System agreed to a $16.5 million settlement in January 2014 over allegations that included unnecessary stents, pacemakers and other cardiac procedures.

Coverage and Coding That Increase the Hospital Bill

Medical device reimbursement fraud allegations produced a $75 million civil settlement with Medtronic Spine, Kyphon’s successor, in May 2008. The Justice Department alleged that Kyphon’s marketing caused hospitals to bill inpatient kyphoplasty when less costly outpatient treatment was clinically appropriate. The sales strategy reached into the hospital’s admission decision.

The defibrillator coverage settlements involved 457 hospitals in the Justice Department’s October 2015 announcement. The government alleged that hospitals implanted medical devices during waiting periods imposed by Medicare’s coverage policy. The investigation used patient-chart review and cardiology expertise to examine the circumstances of the implants.

These cases concern the admission and coverage decisions that produced payment. Manufacturer coding advice adds another connection: what the reimbursement guide told the customer to report, compared with the service actually performed. A product’s authorization, its procedure code, the patient’s coverage and the amount paid need to be followed separately.

Concealed Defects and Adverse-Event Decisions

Defective medical device allegations led to a $30 million civil settlement in October 2013 over Guidant heart medical devices sold for use in Medicare patients. Medicare paid for patients to receive medical devices the government alleged were defective.

The same problem reaches diagnostic testing. Alere agreed to a $33.2 million settlement in March 2018 over allegations that it sold materially unreliable point-of-care tests despite knowing about the problems. A former senior quality-control analyst brought the case.

The internal chronology matters: when complaints arrived, what testing showed, who learned of the problem and what continued to ship. A quality employee may be able to connect a failure pattern with the decision to keep selling the affected product.

Adverse-event reporting files preserve another part of that chronology. Manufacturers must document their deliberations about whether a medical-device-related death, serious injury or malfunction was reportable. A decision to withhold a report can therefore leave its own required record. The complaint file, the reporting decision and the affected units can connect what the company knew with the medical devices used in paid procedures.

Replacement Credits That Never Reach the Payer

Replacement medical device credits can require a reduction in Medicare’s payment. A hospital may receive a free replacement or a credit. The manufacturer’s credit memo and the hospital’s final claim show whether that benefit reached the payer.

The same problem can arise when the government buys directly. St. Jude Medical agreed to pay $3.65 million in a May 2012 settlement over allegations that it withheld warranty credits when billing Defense and Veterans Affairs for replacement pacemakers and defibrillators. Here the government was the buyer owed the credit.

A returned unit, replacement invoice and credit memo can travel through supply chain while a different team submits the claim. That departmental separation is exactly where an insider’s knowledge can matter.

False Country-of-Origin Statements on Federal Medical Device Contracts

Federal medical device procurement fraud can concern false statements about where a medical device was made. Medtronic agreed to a $4.41 million settlement in April 2015 over allegations of false country-of-origin representations in sales to Veterans Affairs and Defense involving medical devices made in China and Malaysia.

Reused Medical Devices and the Instructions Given to Providers

Single-use medical device reuse allegations resulted in a $550,000 civil settlement in March 2025 with The Prometheus Group and its owner. The government alleged that the manufacturer trained providers to reuse rectal sensors and catheters across patients, causing unsafe services billed to Medicare.

The evidence here includes what the manufacturer told providers to do with the product between patients. Training instructions, the medical device’s permitted use and the services billed connect the manufacturer’s conduct to the provider’s claim.

Separately Billed Equipment and Continuing Rentals

Durable medical equipment fraud allegations led to Lincare‘s $25.5 million settlement in February 2024. The company admitted that, in some instances, it kept seeking monthly payments while aware that patients were no longer using the ventilators.

The medical device was the basis of an ongoing supplier bill. The government’s allegations concerned continued rentals after need or use ended and inadequate verification. An employee who knew when use stopped could explain why later bills continued.

Manufacturer kickback allegations involving equipment suppliers were behind Hollister‘s $11.44 million settlement in April 2016. The government alleged that Hollister reimbursed Byram Healthcare for bonuses its salespeople received for each new patient order for a Hollister product. The manufacturer was allegedly buying influence through the supplier’s sales force.

You Know What Happened Before the Bill

If you can explain why a surgeon was paid, why a product problem stayed quiet or why the hospital billed the way it did, speak to one of our Whistleblower Experts about what you saw. We build the strategy with you and find medical device fraud whistleblower lawyers who understand the sales and payment chain. We stay at your side to build your strongest medical device whistleblower case.